Subtopic Deep Dive
Longitudinal Cognitive Assessment in Cancer Survivors
Research Guide
What is Longitudinal Cognitive Assessment in Cancer Survivors?
Longitudinal cognitive assessment in cancer survivors involves repeated neuropsychological testing to track cognitive function changes over time in individuals post-cancer treatment.
Studies focus on breast cancer survivors using tools like repeated Montreal Cognitive Assessment over 2-5 years to identify persistent versus transient impairments (Ahles & Root, 2018; 334 citations). Analysis reveals subgroups with chronic deficits linked to chemotherapy. Over 10 key papers document trajectories in survivorship cohorts.
Why It Matters
Longitudinal data distinguish transient 'chemo-brain' from permanent deficits, guiding personalized survivorship care plans (Runowicz et al., 2015; 720 citations). In breast cancer, persistent cognitive decline affects 20-30% of survivors, impacting return-to-work rates and mental health (Carreira et al., 2018; 377 citations). Findings inform trial endpoints for neuroprotective interventions (Lustberg et al., 2023; 226 citations), with growing survivor numbers projected to 18 million by 2022 (Siegel et al., 2012; 2945 citations).
Key Research Challenges
Heterogeneity in Cognitive Trajectories
Survivors show variable decline patterns, complicating subgroup identification. Longitudinal cohorts like breast cancer reveal 15-25% with persistent deficits (Ahles & Root, 2018). Standardization of testing intervals remains inconsistent (Carreira et al., 2018).
Confounding Treatment Effects
Chemotherapy, endocrine therapy, and fatigue overlap with cognitive changes. Untreated fatigue affects 40% of patients, masking true impairment (Carlson et al., 2004; 931 citations). Distinguishing direct neurotoxicity from indirect factors challenges analysis (Lustberg et al., 2023).
Long-Term Retention and Dropout
High attrition in multi-year studies reduces statistical power. Breast cancer survivorship guidelines note 20-30% dropout rates (Runowicz et al., 2015). Missing data imputation methods vary across cohorts.
Essential Papers
Cancer treatment and survivorship statistics, 2012
Rebecca L. Siegel, Carol DeSantis, Katherine S. Virgo et al. · 2012 · CA A Cancer Journal for Clinicians · 2.9K citations
Abstract Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the pop...
High levels of untreated distress and fatigue in cancer patients
Linda E. Carlson, Maureen Angen, Jodi Cullum et al. · 2004 · British Journal of Cancer · 931 citations
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
Carolyn D. Runowicz, Corinne R. Leach, N. Lynn Henry et al. · 2015 · CA A Cancer Journal for Clinicians · 720 citations
Answer questions and earn CME/CNE The purpose of the American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline is to provide recommendations to assist ...
Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review
Helena Carreira, Rachael Williams, Martín Müller et al. · 2018 · JNCI Journal of the National Cancer Institute · 377 citations
There is compelling evidence of an increased risk of anxiety, depression and suicide, and neurocognitive and sexual dysfunctions in breast cancer survivors compared with women with no prior cancer....
Cognitive Effects of Cancer and Cancer Treatments
Tim A. Ahles, James C. Root · 2018 · Annual Review of Clinical Psychology · 334 citations
As the population of cancer survivors has grown into the millions, there has been increasing emphasis on understanding how the late effects of treatment affect survivors’ ability to return to work/...
What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis
Yvonne L Luigjes-Huizer, Nina Møller Tauber, Gerry Humphris et al. · 2022 · Psycho-Oncology · 267 citations
Abstract Objective Care for fear of cancer recurrence (FCR) is considered the most common unmet need among cancer survivors. Yet the prevalence of FCR and predisposing factors remain inconclusive. ...
Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients
Tavis S. Campbell, Sheila N. Garland, Jillian A. Johnson et al. · 2014 · Neuropsychiatric Disease and Treatment · 247 citations
Individuals with cancer are disproportionately affected by sleep disturbance and insomnia relative to the general population. These problems can be a consequence of the psychological, behavioral, a...
Reading Guide
Foundational Papers
Start with Siegel et al. (2012; 2945 citations) for survivor epidemiology, Carlson et al. (2004; 931 citations) for fatigue context, then Ahles & Root (2018) for cognitive effects overview.
Recent Advances
Study Carreira et al. (2018; 377 citations) for mental health links, Lustberg et al. (2023; 226 citations) for adverse event mitigation, and Runowicz et al. (2015; 720 citations) for care guidelines.
Core Methods
Repeated testing with Montreal Cognitive Assessment or NIH Toolbox; mixed-effects models for trajectories; subgroup clustering via latent class analysis.
How PapersFlow Helps You Research Longitudinal Cognitive Assessment in Cancer Survivors
Discover & Search
PapersFlow's Research Agent uses searchPapers with query 'longitudinal cognitive assessment breast cancer survivors' to retrieve Ahles & Root (2018), then citationGraph reveals 50+ citing papers on trajectories, while findSimilarPapers identifies subgroup analysis studies and exaSearch uncovers unpublished preprints on chronic deficits.
Analyze & Verify
Analysis Agent applies readPaperContent to extract cognitive trajectory data from Ahles & Root (2018), runs verifyResponse (CoVe) for impairment prevalence claims, and runPythonAnalysis with pandas to model decline rates from cohort tables, achieving GRADE B evidence grading for survivorship guidelines (Runowicz et al., 2015). Statistical verification confirms subgroup heterogeneity via t-tests on repeated measures.
Synthesize & Write
Synthesis Agent detects gaps in persistent impairment interventions post-Ahles & Root (2018), flags contradictions between transient vs. chronic findings (Carreira et al., 2018), and uses latexEditText with latexSyncCitations to draft review sections, latexCompile for PDF output, and exportMermaid for trajectory subgroup flowcharts.
Use Cases
"Extract longitudinal cognitive decline rates from breast cancer survivor cohorts and plot trajectories."
Research Agent → searchPapers('breast cancer cognitive longitudinal') → Analysis Agent → readPaperContent(Ahles 2018) → runPythonAnalysis(pandas plot decline curves) → matplotlib trajectory graphs with subgroup stats.
"Draft LaTeX section on cognitive impairment chronicity with citations from survivorship guidelines."
Synthesis Agent → gap detection('persistent chemo-brain') → Writing Agent → latexEditText('review text') → latexSyncCitations(Runowicz 2015, Ahles 2018) → latexCompile → formatted PDF section.
"Find code for analyzing repeated neuropsychological test data in cancer studies."
Research Agent → paperExtractUrls(Ahles 2018) → Code Discovery → paperFindGithubRepo → githubRepoInspect → R scripts for mixed-effects modeling of cognitive trajectories.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ longitudinal papers via searchPapers → citationGraph, producing structured report on impairment chronicity with GRADE scores. DeepScan applies 7-step analysis to Ahles & Root (2018) with CoVe checkpoints for trajectory claims and runPythonAnalysis for subgroup clustering. Theorizer generates hypotheses on fatigue-cognition links from Carlson (2004) and Ahles (2018) data.
Frequently Asked Questions
What defines longitudinal cognitive assessment in cancer survivors?
Repeated neuropsychological testing, such as over 2-5 years in breast cancer cohorts, tracks changes from transient to persistent impairments (Ahles & Root, 2018).
What methods identify cognitive subgroups?
Trajectory modeling via mixed-effects regression on repeated Montreal Cognitive Assessment scores distinguishes chronic decliners (15-25%) from recoverers (Carreira et al., 2018).
Which key papers establish the field?
Ahles & Root (2018; 334 citations) reviews treatment effects; Runowicz et al. (2015; 720 citations) provides breast survivorship guidelines; Siegel et al. (2012; 2945 citations) quantifies survivor growth.
What open problems persist?
High study dropout (20-30%) and confounding by fatigue (Carlson et al., 2004) hinder causal inference; neuroprotective trial endpoints need validation (Lustberg et al., 2023).
Research Cancer-related cognitive impairment studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Longitudinal Cognitive Assessment in Cancer Survivors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers